(Q47382029)

15 January 2018

title

Pravastatin treatment in combined hyperlipidaemia. Effect on plasma lipoprotein levels and size (English)

1 reference

15 January 2018

1 reference

S Zambon

1

1 reference

15 January 2018

A Cortella

2

1 reference

15 January 2018

G Sartore

3

1 reference

15 January 2018

G Baldo-Enzi

4

1 reference

15 January 2018

E Manzato

5

1 reference

15 January 2018

G Crepaldi

6

1 reference

15 January 2018

publication date

1 January 1994

1 reference

15 January 2018

European Journal of Clinical Pharmacology

published in

1 reference

15 January 2018

volume

46

1 reference

15 January 2018

issue

3

1 reference

15 January 2018

page(s)

221-224

1 reference

15 January 2018

https://scigraph.springernature.com/pub.10.1007/bf00192552

exact match

0 references

cites work

Nondenaturing polyacrylamide gradient gel electrophoresis

1 reference

12 December 2020

Lovastatin therapy reduces low density lipoprotein apoB levels in subjects with combined hyperlipidemia by reducing the production of apoB-containing lipoproteins: implications for the pathophysiology of apoB production.

1 reference

12 December 2020

Primary hypertriglyceridemia with borderline high cholesterol and elevated apolipoprotein B concentrations. Comparison of gemfibrozil vs lovastatin therapy

1 reference

12 December 2020

Management of primary mixed hyperlipidemia with lovastatin

1 reference

12 December 2020

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

1 reference

12 December 2020

Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B-containing lipoproteins

1 reference

12 December 2020

The discovery and development of HMG-CoA reductase inhibitors

1 reference

12 December 2020

Changes in Lp(a) lipoprotein levels during the treatment of hypercholesterolaemia with simvastatin

1 reference

12 December 2020

Influence of lovastatin therapy on metabolism of low density lipoproteins in mixed hyperlipidaemia

1 reference

12 December 2020

Treatment of combined hyperlipidemia with lovastatin versus gemfibrozil: a comparison study

1 reference

12 December 2020

[Enzymatic determination of total cholesterol in serum (author's transl)]

1 reference

12 December 2020

Familial combined hyperlipidemia and abnormal lipoprotein lipase

1 reference

12 December 2020

Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia

1 reference

12 December 2020

HMG CoA reductase inhibitors lower LDL cholesterol without reducing Lp(a) levels

1 reference

12 December 2020

Linkage of atherogenic lipoprotein phenotype to the low density lipoprotein receptor locus on the short arm of chromosome 19

1 reference

12 December 2020

Protein measurement with the Folin phenol reagent

1 reference

12 December 2020

Combination drug therapy for familial combined hyperlipidemia

1 reference

12 December 2020

Differential effects of nicotinic acid in subjects with different LDL subclass patterns

1 reference

12 December 2020

Effects of CS-514 on plasma lipids and lipoprotein composition in hypercholesterolemic subjects

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00192552

1 reference

15 January 2018

1 reference

15 January 2018